Abstract

BackgroundSeveral genetic risk factors have been revealed for rheumatoid arthritis (RA) whereof HLA-DRB1 shared epitope alleles and PTPN22 remains the two most undisputed for the disease. Hypotheses for how these...

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
The balance of expression of PTPN22 splice forms is significantly different in rheumatoid arthritis patients compared with controls
Marcus Ronninger ... Padmalatha S Reddy
Genome Medicine | VOL. 4
Marcus Ronninger, et. al.Marcus Ronninger ... Padmalatha S Reddy
01 Jan 2012
Antibody responses to de novo identified citrullinated fibrinogen peptides in rheumatoid arthritis and visualization of the corresponding B cells.
Vijay Joshua ... Philip J Titcombe
Arthritis Research & Therapy | VOL. 18
Vijay Joshua, et. al.Vijay Joshua ... Philip J Titcombe
01 Dec 2016
Different distribution of CD4 and CD8 T cells in synovial membrane and peripheral blood of rheumatoid arthritis and osteoarthritis patients.
J Pawłowska ... E Bryl
Folia Histochemica et Cytobiologica | VOL. 47
J Pawłowska, et. al.J Pawłowska ... E Bryl
01 May 2010
Alternative splicing of the RAGE gene: analysis and characterization in humans and mice
Barry Ian Hudson ... Evis Harja
The FASEB Journal | VOL. 20
Barry Ian Hudson, et. al.Barry Ian Hudson ... Evis Harja
01 Mar 2006
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
Expert consensus recommendations for the diagnosis and treatment of chronic non-bacterial osteitis (CNO) in adults
Elizabeth M Winter ... Anne T Leerling
Annals of the Rheumatic Diseases | VOL. -
Elizabeth M Winter, et. al.Elizabeth M Winter ... Anne T Leerling
28 Nov 2024
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trial
Jinjing Liu ... Xiaofeng Zeng
Annals of the Rheumatic Diseases | VOL. -
Jinjing Liu, et. al.Jinjing Liu ... Xiaofeng Zeng
27 Nov 2024
CD-19 CAR-T cells for polyrefractory rheumatoid arthritis
Merav Lidar ... Abraham Avigdor
Annals of the Rheumatic Diseases | VOL. -
Merav Lidar, et. al.Merav Lidar ... Abraham Avigdor
27 Nov 2024
Correction: Olokizumab plus methotrexate: safety and efficacy over 106 weeks of treatment
-
Annals of the Rheumatic Diseases | VOL. -
--
27 Nov 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.